Recombinant Interferon Alfa-2b Therapy in Children with Immune Thrombocytopenic Purpura

Ammar Hayani Department of Pediatrics, Section of Hematology/Oncology, Texas Children's Hospital and Baylor College of Medicine, Houston, Texas

Donald H. Mahoney Department of Pediatrics, Section of Hematology/Oncology, Texas Children's Hospital and Baylor College of Medicine, Houston, Texas

C. Philip Steuber Department of Pediatrics, Section of Hematology/Oncology, Texas Children's Hospital and Baylor College of Medicine, Houston, Texas

Abdus Saleem Department of Pathology, Baylor College of Medicine, Houston, Texas

References

Mylvaganam R, Garcia R O, Ahn Y S, Sprinz P G, Kim C I, Harrington W J. Depressed functional and phenotypic properties of T but not B lymphocytes in idiopathic thrombocytopenic purpura. Blood. 1988; 71: 1455–1460
PubMedGoogle Scholar
Herberman R R, Ortaldo J R, Bonnard G D. Augmentation by interferon of human natural and antibody-dependent cell-mediated cytotoxicity. Nature 1979; 277: 221–223
PubMed Web of Science ®Google Scholar
Proctor S J, Jackson G, Carey P. Improvement of platelet count in steroid-unresponsive idiopathic immune thrombocytopenic purpura after short course therapy with recombinant alpha 2b interferon. Blood. 1989; 74: 1894–1897
PubMed Web of Science ®Google Scholar
Bellucci S, Bordessoule D, Coiffier B, Tabah I. Interferon alpha-2b therapy in adult chronic thrombocytopenia purpura (ITP). Br J Haematol. 1989; 73: 578–579
PubMed Web of Science ®Google Scholar
Hurtado R, Pita L, Karpovitch X L. Recombinant interferon alfa-2b in refractory idiopathic immune thrombocytopenia. Blood. 1990; 75: 1744–1745
PubMedGoogle Scholar
Facon T, Caulier M T, Fenaux P. Interferon alpha-2b therapy in refractory adult chronic thrombocytopenic. Br J Haematol. 1991; 78: 464–467
PubMedGoogle Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Recombinant Interferon Alfa-2b Therapy in Children with Immune Thrombocytopenic Purpura

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Recombinant Interferon Alfa-2b Therapy in Children with Immune Thrombocytopenic Purpura

References

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date